omega-n-methylarginine has been researched along with flesinoxan in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (flesinoxan) | Trials (flesinoxan) | Recent Studies (post-2010) (flesinoxan) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 154 | 11 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blauw, GJ; Bruning, TA; Chang, PC; van Zwieten, PA | 1 |
| Bruning, TA; Van Zwieten, PA | 1 |
1 trial(s) available for omega-n-methylarginine and flesinoxan
| Article | Year |
|---|---|
No functional involvement of 5-hydroxytryptamine1A receptors in nitric oxide-dependent dilatation caused by serotonin in the human forearm vascular bed.
Topics: Adult; Arginine; Dose-Response Relationship, Drug; Forearm; Hemodynamics; Humans; Injections, Intra-Arterial; Male; Nitric Oxide; omega-N-Methylarginine; Piperazines; Plethysmography; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Regional Blood Flow; Serotonin; Serotonin Receptor Agonists; Vascular Resistance; Vasodilation | 1994 |
1 other study(ies) available for omega-n-methylarginine and flesinoxan
| Article | Year |
|---|---|
Comparison of the hemodynamic effects of urapidil and flesinoxan in healthy volunteers.
Topics: Adult; Antihypertensive Agents; Arginine; Dose-Response Relationship, Drug; Doxazosin; Hemodynamics; Humans; Male; Methoxamine; omega-N-Methylarginine; Piperazines; Regional Blood Flow; Serotonin; Vascular Resistance | 1994 |